home / stock / iccc / iccc news


ICCC News and Press, ImmuCell Corporation

Stock Information

Company Name: ImmuCell Corporation
Stock Symbol: ICCC
Market: NASDAQ
Website: immucell.com

Menu

ICCC ICCC Quote ICCC Short ICCC News ICCC Articles ICCC Message Board
Get ICCC Alerts

News, Short Squeeze, Breakout and More Instantly...

ICCC - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024

PORTLAND, Maine, July 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

ICCC - ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®

PORTLAND, Maine , June 05, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the he...

ICCC - ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript

2024-05-15 13:48:05 ET ImmuCell Corporation (ICCC) Q1 2024 Results Conference Call May 15, 2024 9:00 AM ET Company Participants Joe Diaz - Lytham Partners Michael Brigham - President & CEO Conference Call Participants Michael Potter - Monarch Capital ...

ICCC - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

PORTLAND, Maine, May 14, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health an...

ICCC - Expected US Company Earnings on Thursday, May 9th, 2024

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

ICCC - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

PORTLAND, Maine, May 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health an...

ICCC - (ICCC) Investment Report

2024-04-17 08:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ICCC - ImmuCell reports preliminary Q1 sales, stock climbs 7%

2024-04-09 16:47:58 ET More on ImmuCell ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript Financial information for ImmuCell Read the full article on Seeking Alpha For further details see: ImmuCell reports preliminary Q1 sales, stock climbs 7%

ICCC - ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health ...

ICCC - Long Term Trading Analysis for (ICCC)

2024-04-07 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Next 10